Differential infectivity and immunopathology in murine experimental infections by two natural clones belonging to the Trypanosoma cruzi I lineage

Parasitology

Volumn 131, Issue 1, 2005, Pages 109-119

  Garzon, E ^a   Genna, F ^a   Bosseno, M F ^a   Simony La Fontaine, J ^b   Radal, M ^b   Sereno, D ^a   Mathieu Daude, F ^a   Ouaissi, A ^a   Breniere S F ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b CENTRE VAL D AURELLE   (France)

Author keywords

Genotype; Immunopathology; Mouse; Trypanosoma cruzi; Virulence

Indexed keywords

CD8 ANTIGEN; IMMUNOGLOBULIN G2A;

ARTICLE; CELL LINEAGE; CELL STRAIN L 929; CHAGAS DISEASE; CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; GENOTYPE; HISTOPATHOLOGY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PARASITEMIA; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; T LYMPHOCYTE; TISSUE INJURY; TRYPANOSOMA CRUZI; VIRULENCE;

ANIMALS; CELL LINE; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; FIBROBLASTS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MYOSITIS; TIME FACTORS; TRYPANOSOMA CRUZI;

MURINAE; TRYPANOSOMA CRUZI;

EID: 22444449315     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S003118200400722X     Document Type: Article

References (40)

1. ANDRADE, S. G. & MAGALHAES, J. B. (1996). Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Revista da Sociedade Brasileira de Medicina Tropical 30, 27-35.
2. BARRETT, M. P., BURCHMORE, R. J., STICH, A., LAZZARI, J. O., FRASCH, A. C., CAZZULO, J. J. & KRISHNA, S. (2003). The trypanosomiases. Lancet 362, 1469-1480.
3. BARNABÉ, C., BRISSE, S. & TIBAYRENC, M. (2000). Population structure and genetic typing of Trypanosoma cruzi, the agent of Chagas disease: a multilocus enzyme electrophoresis approach. Parasitology 120, 513-526.
4. BOSSENO, M. F., BARNABE, C., MAGALLON GASTELUM, E., LOZANO KASTEN, F., RAMSEY, J., ESPINOZA, B. & BRENIERE, S. F. (2002). Predominance of Trypanosoma cruzi lineage I in Mexico. Journal of Clinical Microbiology 40, 627-632.
5. BRENER, Z. (1962). Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de São Paulo 4, 389-396.
6. BRENIÈRE, S. F., CARRASCO, R., REVOLLO, S., APARICIO, G., DESJEUX, P. & TIBAYRENC, M. (1989). Chagas' disease in Bolivia: clinical and epidemiological features and zymodeme variability of Trypanosoma cruzi strains isolated from patients. American Journal of Tropical Medicine and Hygiene 41, 521-529.
7. BRENIÈRE, S. F., BRAQUEMOND, P., SOLARI, A., AGNÈSE, J. F. & TIBAYRENC, M. (1991). An isoenzyme study of naturally occurring clones of Trypanosoma cruzi isolated from both sides of the West Andes highland. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 62-66.
8. BRISSE, S., DUJARDIN, J. C. & TIBAYRENC, M. (2000). Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Molecular and Biochemical Parasitology 111, 95-105.
9. CARNEIRO, M., ROMANHA, A. J. & CHIARI, E. (1991). Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Memorias do Instituto Oswaldo Cruz 86, 387-393.
10. CLARK, C. G. & PUNG, O. J. (1994). Host specificity of ribosomal DNA variation in sylvatic Trypanosoma cruzi from North America. Molecular and Biochemical Parasitology 66, 175-179.
11. DE DIEGO, J. A., PAULAU, M. T. & PENIN, P. (1998). Are genotypes of Trypanosoma cruzi involved in the challenge of chagasic cardiomyopathy? Parasitology Research 84, 147-152.
12. DI NOIA, J. M., BUSCAGLIA, C. A., DE MARCHI, C. R., ALMEIDA, I. C. & FRASCH, A. C. (2002). A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. The Journal of Experimental Medicine 195, 401-413.
13. DOS SANTOS, P. V., ROFFE, E., SANTIAGO, H. C., TORRES, R. A., MARINO, A. P., PAIVA, C. N., SILVA, A. A., GAZZINELLI, R. T. & LANNES-VIEIRA, J. (2001). Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1 (High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes and Infection 3, 971-984.
14. DOST, C. K., SARAIVA, J., MONESI, N., ZENTGRAF, U., ENGELS, W. & ALBUQUERQUE, S. (2004). Six Trypanosoma cruzi strains characterized by specific gene expression patterns. Parasitology Research, Aug 19 [Epub ahead of print].
15. FRANCOLINO, S. S., ANTUNES, A. F., TALICE, R., ROSA, R., SELANIKIO, J., DE REZENDE, J. M., ROMANHA, A. J. & DIAS, J. C. (2003). New evidence of spontaneous cure in human Chagas' disease. Revista da Sociedade Brasileira de Medicina Tropical 36, 103-107.
16. GARZON, E., BORGES, M. C., CORDEIRO-DA-SILVA, A., NACIFE, V., MEIRELLES MDE, N., GUILVARD, E., BOSSENO, M. F., GUEVARA, A. G., BRENIERE, S. F. & OUAISSI, A. (2003). Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice. Immunology Letters 89, 67-80.
17. HIGO, H., YANAGI, T., MATTA, V., AGATSUMA, T., KANBARA, H., TADA, I., DE LEON, M. P., MONROY, C. & TABARU, Y. (1997). Genetic structure of Trypanosoma cruzi in Central America and its comparison with South American strains. International Journal for Parasitology 27, 1369-1374.
18. KALIL, J. & CUNHA-NETO, E. (1996). Autoimmunity in Chagas Disease cardiomyopathy: Fulfilling the criteria at last? Parasitology Today 12, 396-398.
19. KIERSZENBAUM, F., LOPEZ, H. M. & SZTEIN, M. B. (1994). Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease. Immunology 81, 462-467.
20. KRAUTZ, G. M., KISSINGER, J. C. & KRETTLI, A. U. (2000). The targets of the lytic antibody response against Trypanosoma cruzi. Parasitology Today 16, 31-34.
21. LAURENT, J. P., BARNABÉ, C., QUESNEY, V., NOEL, S. & TIBAYRENC, M. (1997). Impact of clonal evolution on the biological diversity of Trypanosoma cruzi. Parasitology 114, 213-218.
22. LEON, J. S. & ENGMAN, D. M. (2003). The significance of autoimmunity in the pathogenesis of Chagas heart disease. Frontiers in Bioscience 8, 315-322.
23. MARINHO, C. R., D'IMPERIO LIMA, M. R., GRISOTTO, M. G. & ALVAREZ, J. M. (1999). Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infection and Immunity 67, 308-318.
24. MILES, M. A., CEDILLOS, R. A., POVOA, M. M., DE SOUZA, A. A., PRATA, A. & MACEDO, V. (1981). Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease? Lancet 20, 1338-1340.
25. MINOPRIO, P. (2001). Parasite polyclonal activators: new targets for vaccination approaches? International Journal for Parasitology 31, 588-591.
26. MINOPRIO, P. M., EISEN, H., FORNI, L., D'IMPERIO LIMA, M. R., JOSKOWICZ, M. & COUTINHO, A. (1986). Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scandinavian Journal of Immunology 24, 661-668.
27. MOMEN, H. (1999). Taxonomy of Trypanosoma cruzi: a commentary on characterization and nomenclature. Memorias do Instituto Oswaldo Cruz 94 (Suppl.) 181-184.
28. MONTILLA, M. M., GUHL, F., JARAMILLO, C., NICHOLLS, S., BARNABE, C., BOSSENO, M. F. & BRENIERE, S. F. (2002). Isoenzyme clustering of Trypanosomatidae Colombian populations. American Journal of Tropical Medicine and Hygiene 66, 394-400.
29. MOSER, D. R., KIRCHHOFF, L. V. & DONELSON, J. E. (1989). Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. Journal of Clinical Microbiology 27, 1477-1482.
30. OUAISSI, A., DA SILVA, A. C., GUEVARA, A. G., BORGES, M. & GUILVARD, E. (2001). Trypanosoma cruzi-induced host immune system dysfunction: a rationale for parasite immunosuppressive factor(s) encoding gene targeting. Journal of Biomedicine and Biotechnology 1, 11-17.
31. REINA-SAN-MARTIN, B., COSSON, A. & MINOPRIO, P. (2000). Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitology Today 16, 62-67.
32. REVOLLO, S., OURY, B., LAURENT, J. P., BARNABE, C., QUESNEY, V., CARRIERE, V., NOEL, S. & TIBAYRENC, M. (1998). Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Experimental Parasitology 89, 30-39.
33. RISSO, M. G., GARBARINO, G. B., MOCETTI, E., CAMPETELLA, O., GONZALEZ CAPPA, S. M., BUSCAGLIA, C. A. & LEGUIZAMON, M. S. (2004). Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. Journal of Infectious Diseases 189, 2250-2259.
34. SOUTO, R. P., FERNANDES, O., MACEDO, A. M., CAMPBELL, D. A. & ZINGALES, B. (1996). DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Molecular and Biochemical Parasitology 83, 141-152.
35. SPINELLA, S., MILON, G. & HONTEBEYRIE-JOSKOWICZ, M. (1990). A CD4+ TH2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo. European Journal of Immunology 20, 1045-1051.
36. STEINDEL, M., TOMA, H. K., ISHIDA, M. M., MURTA, S. M., DE CARVALHO PINTO, C. J., GRISARD, E. C., SCHLEMPER BR, J. R., RIBEIRO-RODRIGUES, R. & ROMANHA, A. J. (1995). Biological and isoenzymatic characterization of Trypanosoma cruzi strains isolated from sylvatic reservoirs and vectors from the state of Santa Catarina, Southern Brazil. Acta Tropica 60, 167-177.
37. TAIBI, A., ESPINOZA, A. G. & OUAISSI, A. (1995). Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease. Immunology Letters 48, 193-200.
38. TOLEDO, M. J., DE LANA, M., CARNEIRO, C. M., BAHIA, M. T., MACHADO-COELHO, G. L., VELOSO, V. M., BARNABE, C., TIBAYRENC, M. & TAFURI, W. L. (2002). Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Experimental Parasitology 100, 161-172.
39. WORLD HEALTH ORGANIZATION (2002). Control of Chagas Disease. Second Report of the WHO Expert committee, Geneva.
40. ZINGALES, B., STOLF, B. S., SOUTO, R. P., FERNANDES, O. & BRIONES, M. R. (1999). Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. Memorias do Instituto Oswaldo Cruz 94 (Suppl 1), 159-164.